Medical Facilities Corporation
TSX:DR.TOMedical - Care Facilities
+$0.18 today
- Market cap
- $282.59M
- Beta
- 0.34
- P/E (TTM)
- 8.7
- EPS (TTM)
- $1.47
- Dividend yield
- 2.00%
Volume 0.04M
Average 0.02M
DR.TO Accounts Payables
Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.
Medical Facilities CorporationTSX: DR.TO
Accounts Payables · Q1 FY2026 · quarter ended Mar 2026
Accounts payables dips below year-ago levels
Q1 FY2026 accounts payables of $936.4K (cash outflow) fell 73.5% year over year, behind the +349.5% change in trailing-twelve-month accounts payables. Over 3 fiscal years it compounded at -8.9% a year.
Context
- Accounts payables amounted to 0.7% of revenue in FY2025, up 0.6 pp from a year earlier.
- Accounts payables increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -73.5% toward the trailing-twelve-month pace of +349.5%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Payables history
USD · from the cash flow
- Latest · FY2025
- 1.86M USD
- Year-over-year change
- +475.8%
| Period | Period end | Accounts Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.86M | +475.8% |
| FY2024 | 2024-12-31 | (495K) | +80.1% |
| FY2023 | 2023-12-31 | (2.48M) | -200.9% |
| FY2022 | 2022-12-31 | 2.46M | +569.0% |
| FY2021 | 2021-12-31 | (525K) | — |
Accounts Payables vs competitors
How DR.TO compares with its peers on the latest reported figures
- Peers report in different currencies, so accounts payables is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +349.5% is the 2nd highest of 8, against a peer median of -71.9%.
- Accounts payables amounts to 1.5% of revenue for DR.TO, versus a peer median of 1.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | CA$6.02M CAD | -234.6% | — | 3.8% | |
| LTM Mar 2026 | CA$5.6M CAD | -185.0% | — | 1.5% | |
| LTM Mar 2026 | $4.49M USD | +349.5% | -8.9% | 1.5% | |
| LTM Mar 2026 | CA$4.35M CAD | -71.9% | — | 1.4% | |
| LTM Mar 2026 | $3.31M USD | +279.8% | +22.0% | — | |
| LTM Mar 2026 | $3.14M USD | -22.4% | -33.7% | 1.2% | |
| LTM Mar 2026 | $973.33K USD | +1180.7% | -4.7% | 1.9% | |
PRN.TOProfound Medical Corp. | LTM Mar 2026 | $379.28K USD | -77.5% | — | 2.0% |
| LTM Mar 2026 | CA$0 CAD | — | — | 0.0% | |
| Peer median (excluding DR.TO) | — | -71.9% | -4.7% | 1.5% | |
Competitors are the stored peer set for DR.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 46.49M | 12.3M | 44M | 105.56M | 21.08M |
| Depreciation & Amortization | 26.77M | 20.76M | 21.54M | 19.37M | 15.66M |
| Deferred Income Tax | 4.4M | 5.21M | 8.33M | (3.67M) | 6.01M |
| Stock-Based Compensation | 292K | (667K) | (397K) | (246K) | 0 |
| Change in Working Capital | (10.45M) | (6.21M) | (488K) | (1.64M) | (3.96M) |
| Accounts Receivables | (1.23M) | (2.6M) | 1.03M | 5.23M | (4.02M) |
| Inventory | 659K | 1.42M | (205K) | (476K) | (659.34K) |
| Accounts Payables | (525K) | 2.46M | (2.48M) | (495K) | 1.86M |
| Other Working Capital | (9.35M) | (7.5M) | 1.17M | (5.9M) | (1.14M) |
| Other Non-Cash Items | 8.14M | 25.63M | (183K) | (36.09M) | 7.16M |
| Operating Cash Flow | 75.64M | 57.01M | 72.71M | 83.28M | 45.95M |
| Capital Expenditures | (8.42M) | (6.72M) | (16.05M) | (7.07M) | (4.96M) |
| Acquisitions (Net) | (267K) | 943K | 2.39M | 92.49M | 826.21K |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (267K) | 943K | 2.39M | 0 | 0 |
| Investing Cash Flow | (8.69M) | (5.78M) | (13.67M) | 85.42M | (4.14M) |
| Debt Repayment | (30.05M) | (6.47M) | (28.84M) | (32.82M) | (2.62M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (2.07M) | (38.38M) | (7.42M) | (16.61M) | (64.78M) |
| Dividends Paid | (6.92M) | (7.5M) | (6.07M) | (6.1M) | (5.18M) |
| Other Financing Activities | (33.02M) | (25M) | (27.49M) | (28.73M) | (34.72M) |
| Financing Cash Flow | (72.06M) | (77.35M) | (69.83M) | (84.26M) | (107.3M) |
| Effect of Forex Changes | (34K) | (3K) | (34K) | (59K) | (4.77M) |
| Net Change in Cash | (5.14M) | (26.12M) | (10.81M) | 84.38M | (70.26M) |
| Free Cash Flow | 67.22M | 50.3M | 56.66M | 76.22M | 40.99M |
Medical Facilities Corporation
TSX:DR.TO
Intrinsic Alpha fair value
Locked
Current Price
$17.43
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.